KIMIA MIRABBASZADEH: Open Payments
NPI 1013795772 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $93 |
| Amgen Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, Wegovy, REPATHA, JARDIANCE, MOUNJARO.
Industry payments across NY — which companies pay providers there.
